Australia - angielski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - azoxystrobin(120g/l)+tebuconazole(200g/l) - group 11/3 fungicide

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

allergan, inc. - tazarotene (unii: 81bdr9y8ps) (tazarotene - unii:81bdr9y8ps) - tazarotene 0.5 mg in 1 g - tazorac® (tazarotene) gel, 0.05% and 0.1% are indicated for the topical treatment of patients with plaque psoriasis of up to 20% body surface area involvement. tazorac (tazarotene) gel, 0.1% is also indicated for the topical treatment of patients with facial acne vulgaris of mild to moderate severity. the efficacy of tazorac gel in the treatment of acne previously treated with other retinoids or resistant to oral antibiotics has not been established. the safety of tazorac gel use on more than 20% body surface area has not been established in psoriasis or acne [see warnings and precautions ( 5.1 ) and use in specific populations ( 8.1 )]. tazorac gel is contraindicated in:  - pregnancy. retinoids may cause fetal harm when administered to a pregnant female [see warnings and precautions ( 5.1 ), use in specific populations ( 8.1 , 8.3 )]. - individuals who have known hypersensitivity to any of its components [see warnings and precautions ( 5.2 )]. risk summary based on data from animal reproduction studies, ret

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

allergan, inc. - tazarotene (unii: 81bdr9y8ps) (tazarotene - unii:81bdr9y8ps) - tazarotene 0.5 mg in 1 g - tazorac® (tazarotene) cream, 0.05% and 0.1% are indicated for the topical treatment of patients with plaque psoriasis. tazorac (tazarotene) cream, 0.1% is also indicated for the topical treatment of patients with acne vulgaris. tazorac cream is contraindicated in : - pregnancy. retinoids may cause fetal harm when administered to a pregnant female [see warnings and precautions (5.1), use in specific populations (8.1, 8.3)] . - individuals who have known hypersensitivity to any of its components [see warnings and precautions (5.2)]. risk summary based on data from animal reproduction studies, retinoid pharmacology, and the potential for systemic absorption, tazorac cream may cause fetal harm when administered to a pregnant female and is contraindicated during pregnancy. safety in pregnant females has not been established. the potential risk to the fetus outweighs the potential benefit to the mother from tazorac cream during pregnancy; therefore, tazorac cream should be discontinued as soon as pregnancy is re

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

physicians total care, inc. - tazarotene (unii: 81bdr9y8ps) (tazarotene - unii:81bdr9y8ps) - tazarotene 1 mg in 1 g - tazorac® (tazarotene) gel 0.05% and 0.1% are indicated for the topical treatment of patients with stable plaque psoriasis of up to 20% body surface area involvement. tazorac® (tazarotene) gel 0.1% is also indicated for the topical treatment of patients with facial acne vulgaris of mild to moderate severity. the efficacy of tazorac® gel in the treatment of acne previously treated with other retinoids or resistant to oral antibiotics has not been established. retinoids may cause fetal harm when administered to a pregnant woman. in rats, tazarotene 0.05% gel, administered topically during gestation days 6 through 17 at 0.25 mg/kg/day (1.5 mg/m2 /day) resulted in reduced fetal body weights and reduced skeletal ossification. rabbits dosed topically with 0.25 mg/kg/day (2.75 mg/m2 total body surface area/day) tazarotene gel during gestation days 6 through 18 were noted with single incidences of known retinoid malformations, including spina bifida, hydrocephaly, and heart anomalies. systemic daily

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

almirall, llc - tazarotene (unii: 81bdr9y8ps) (tazarotene - unii:81bdr9y8ps) - tazorac® (tazarotene) cream, 0.05% and 0.1% are indicated for the topical treatment of patients with plaque psoriasis. tazorac (tazarotene) cream, 0.1% is also indicated for the topical treatment of patients with acne vulgaris. tazorac cream is contraindicated in: - pregnancy. retinoids may cause fetal harm when administered to a pregnant female [see warnings and precautions (5.1), use in specific populations (8.1, 8.3)] . - individuals who have known hypersensitivity to any of its components [see warnings and precautions (5.2)] . risk summary based on data from animal reproduction studies, retinoid pharmacology, and the potential for systemic absorption, tazorac cream may cause fetal harm when administered to a pregnant female and is contraindicated during pregnancy. safety in pregnant females has not been established. the potential risk to the fetus outweighs the potential benefit to the mother from tazorac cream during pregnancy; therefore, tazorac cream should be discontinued as soon as pregnancy is re

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

almirall, llc - tazarotene (unii: 81bdr9y8ps) (tazarotene - unii:81bdr9y8ps) - tazorac® (tazarotene) gel, 0.05% and 0.1% are indicated for the topical treatment of patients with plaque psoriasis of up to 20% body surface area involvement. tazorac (tazarotene) gel, 0.1% is also indicated for the topical treatment of patients with facial acne vulgaris of mild to moderate severity. the efficacy of tazorac gel in the treatment of acne previously treated with other retinoids or resistant to oral antibiotics has not been established. the safety of tazorac gel use on more than 20% body surface area has not been established in psoriasis or acne [see warnings and precautions ( 5.1 ) and use in specific populations ( 8.1 )]. tazorac gel is contraindicated in:  - pregnancy. retinoids may cause fetal harm when administered to a pregnant female [see warnings and precautions ( 5.1 ), use in specific populations ( 8.1 , 8.3 )]. - individuals who have known hypersensitivity to any of its components [see warnings and precautions ( 5.2 )]. risk summary based on data from animal reproduction studies, ret

Australia - angielski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

axichem pty ltd - azoxystrobin - suspension concentrate - azoxystrobin pyrimidine active 250.0 g/l - fungicide

Australia - angielski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

amgrow pty ltd - azoxystrobin; tetrahydrofurfuryl alcohol - dispersible concentrate - azoxystrobin pyrimidine active 95.0 g/l; tetrahydrofurfuryl alcohol ungrouped other 706.0 g/l - fungicide - turf - anthracnose - colletotrichum graminicola | brown patch - rhizoctonia solani | grey leaf spot - pyricularia grisea | helminthosporium disease | phytophthora parasitica | pythium spp. | red thread | wilt rootrot or damping off | winter fusarium | bipolaris spp. | damping off seedling | damping-off | drechslera dermatiodia | drechslera spp. | exserohilum spp. | grease spot | helminthosporium disease patch | helminthosporium leaf spot | helminthosporium spot | leaf blight - helminthosporium | pythium blight | pythium root rot | pythium soil fungus | seedling root rot | soil fungi | white helminthosporium

Australia - angielski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

kenso corporation (m) sdn. bhd. - azoxystrobin - water dispersible granule - azoxystrobin pyrimidine active 800.0 g/kg - fungicide - avocado | cucurbit | grape - currant (dried fruit) | grape - sultana (dried fruit) | grape - table | grape - wine | mango | pass - alternaria leaf spot - alternaria spp. | anthracnose | bunch rot | cladosporium | downy mildew | downy mildew on cucurbit | downy mildew on grape | early blight or target blackspot | gummy stem blight - didymella bryoniae | late blight or irish blight | powdery mildew on cucurbit | powdery mildew on grapevine | sclerotinia minor | stem end rot - phomopsis citri | irish blight | melanose | sphaerotheca fuliginea | stem-end rot | target spot

Australia - angielski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

upl australia pty ltd - azoxystrobin - suspension concentrate - azoxystrobin pyrimidine active 250.0 g/l - fungicide - avocado plantation | cucurbit | grape - currant (dried fruit) | grape - table | grape - wine | mango plantation | passionfruit p - alternaria rot | anthracnose | black stem canker scurf | botrytis cinerea | cladosporium | downy mildew | downy mildew on cucurbit | downy mildew on grape | early blight (target spot) | gummy stem blight - didymella bryoniae | late blight or irish blight | powdery mildew on cucurbit | powdery mildew on grapevine | sclerotinia minor | silver scurf | stem end rot - phomopsis citri | black scurf | canker | damping off | hypocotyl rot | irish blight | melanose | root rot | soil fungi | sphaerotheca fuliginea | stem-end rot | target spot | wire stem